| LKEQX | RGAHX | LKEQX / RGAHX | |
| Total Expense Ratio | 0.80 | 0.44 | 182% |
| Annual Report Gross Expense Ratio | 0.98 | 0.44 | 223% |
| Fund Existence | 30 years | 10 years | - |
| Gain YTD | 7.945 | 15.986 | 50% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 250 | 800% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 510M | 327B | 0% |
| Annual Yield % from dividends | 0.44 | 0.44 | 101% |
| Returns for 1 year | -2.48 | 7.06 | -35% |
| Returns for 3 years | 20.65 | 63.22 | 33% |
| Returns for 5 years | 19.64 | 34.78 | 56% |
| Returns for 10 years | 84.04 | 89.07 | 94% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SIXZ | 28.92 | 0.11 | +0.38% |
| AllianzIM US Lrg Cp 6M Bfr10 May/Nov ETF | |||
| REVS | 27.59 | -0.05 | -0.18% |
| Columbia Research Enhanced Value ETF | |||
| BBH | 189.89 | -0.62 | -0.33% |
| VanEck Biotech ETF | |||
| IDMO | 53.02 | -0.25 | -0.47% |
| Invesco S&P International Dev Momt ETF | |||
| DIVG | 31.64 | -0.24 | -0.75% |
| Invesco S&P 500 Hi Div Grwrs ETF | |||